COmmunity Mistrust and Measures of Institutional Trustworthiness (COMMIT)

项目摘要/摘要 在美国，服务不足和社会弱势群体遭受了更高的死亡率 以及新冠肺炎感染、发病率和死亡率的差异。这种不成比例的负担 揭示了新冠肺炎差距的根本原因，如长期存在的系统性差距 医疗保健提供中的种族偏见、歧视和不良的健康社会决定因素 导致健康方面的差异，如哮喘、糖尿病、高血压和 肥胖，所有这些都增加了患新冠肺炎及其后遗症的风险和易感性。致信地址 这些根本原因、学术和其他研究机构以及医疗保健系统必须转变 他们的镜头来自于只专注于改变服务不足和 弱势群体。医疗保健和研究机构的行为必须改变为 破解新冠肺炎信任、检测、治疗、预防的结构性壁垒。之前 对于要求患者和社区成员信任研究和研究人员，重点 应该进行彻底的制度改革，以提高可信度。 努力解决影响访问可接受性的社会、道德和行为问题(SEBI) 在大流行期间采用新冠肺炎检测极具挑战性，但是可以实现的 当存在现有的社区-学术合作伙伴关系时。信任和信任的区别 可信性表明，可信度是信任的先决条件。我们建议的研究将 采用持续参与的方法来提升机构可信度和 加强现有社区参与研究(CENR)伙伴关系的力量，以及 为建立类似的机构间伙伴关系提出建议 服务不足人口中的社区组织。 通过与社区和社区药房合作伙伴的合作，我们的目标是： 目标1：共同设计一个可持续的值得信赖的中心伙伴关系模式，以解决 新冠肺炎测试 目标2：评估值得信赖的中心合作伙伴关系的最佳实践，以解决新冠肺炎测试问题 SEBI因素 目标3：共同制定符合道德规范的承诺备忘录模板 新冠肺炎测试中心合作伙伴关系通过可信度提高信任， 透明度和尊重

PROJECT SUMMARY/ABSTRACT In the United States underserved and socially vulnerable populations have endured higher rates and disparities of COVID-19 infection, morbidity, and mortality. This disproportionate burden has shown the light on the root causes of COVID-19 disparities such as longstanding systemic racial bias in health care delivery, discrimination, and poor social determinants of health that lead to health disparities for medical conditions such as asthma, diabetes, hypertension, and obesity, all of which increase risk and susceptibility to COVID-19 and its sequalae. To address these root causes, academic and other research institutions and health care systems must shift their lens from one that focuses solely on changing behaviors among underserved and vulnerable populations. Behaviors among health care and research institutions must change to breakdown the structural barriers to trust, testing, treatment, and prevention of COVID-19. Prior to asking patients and community members to trust in research and researchers, the focus should be on radical institutional transformation to advance trustworthiness. Trying to address social, ethical, and behavioral issues (SEBI) influencing access acceptability and uptake of COVID-19 testing during a pandemic is extremely challenging, yet achievable when there are existing community-academic partnerships. The distinction between trust and trustworthiness suggests that trustworthiness is an antecedent to trust. Our proposed study will employ a continuous engagement approach to advance institutional trustworthiness and improve the strength of an existing community-engaged research (CEnR) partnership as well as develop recommendations for the formation of similar inter-institutional partnerships with community organizations in underserved populations. In collaboration with community and community-based pharmacy partners, our Aims are: Aim 1: Codesign a sustainable model for trustworthy CEnR partnerships to address SEBI of COVID-19 testing Aim 2: Assess best practices of trustworthy CEnR partnerships to address COVID-19 testing SEBI factors Aim 3: Codevelop an ethically-congruent memorandum of commitment (MOC) template for CEnR partnerships for COVID-19 testing to advance trust through trustworthiness, transparency, and respect